市場調査レポート
商品コード
1184188

整形外科用成長因子の世界市場:規模、シェア、COVID-19の影響分析(2023年~2029年):MedCore

Orthopedic Growth Factor Market Size, Share, and COVID-19 Impact Analysis | Global | 2023-2029 | MedCore

出版日: | 発行: iData Research Inc. | ページ情報: 英文 31 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
整形外科用成長因子の世界市場:規模、シェア、COVID-19の影響分析(2023年~2029年):MedCore
出版日: 2022年12月30日
発行: iData Research Inc.
ページ情報: 英文 31 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の整形外科用成長因子の市場規模は、2022年に8億6,000万米ドルとなりました。同市場は、予測期間中に3.5%のCAGRで拡大し、11億米ドルに達すると予測されています。

当レポートでは、世界の整形外科用成長因子市場について調査し、市場の概要とともに、セグメント別、地域別動向、競合情勢などを提供しています。

目次

整形外科用成長因子市場

  • エグゼクティブサマリー
  • イントロダクション
  • 手技件数
  • 市場分析と予測
  • 促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 競合市場シェア分析
図表

LIST OF CHARTS

  • Chart 6-1: Orthopedic Growth Factor Market, Global, 2022 & 2029
  • Chart 6-2: Orthopedic Growth Factor Procedures, Global, 2022
  • Chart 6-3: Orthopedic Growth Factor Procedures by Segment, Global, 2019 - 2029
  • Chart 6-4: Orthopedic Growth Factor Device Market, Global, 2019 - 2029
  • Chart 6-5: Leading Competitors, Orthopedic Growth Factor Market, Global, 2022

LIST OF FIGURES

  • Figure 6-1: Orthopedic Growth Factor Procedures by Region, Global, 2019 - 2029
  • Figure 6-2: Orthopedic Growth Factor Procedures by Country, North America, 2019 - 2029
  • Figure 6-3: Orthopedic Growth Factor Procedures by Country, Latin America, 2019 - 2029 (1 of 2)
  • Figure 6-4: Orthopedic Growth Factor Procedures by Country, Latin America, 2019 - 2029 (2 of 2)
  • Figure 6-5: Orthopedic Growth Factor Procedures by Country, Western Europe, 2019 - 2029
  • Figure 6-6: Orthopedic Growth Factor Procedures by Country, Central & Eastern Europe, 2019 - 2029 (1 of 2)
  • Figure 6-7: Orthopedic Growth Factor Procedures by Country, Central & Eastern Europe, 2019 - 2029 (2 of 2)
  • Figure 6-8: Orthopedic Growth Factor Procedures by Country, Middle East, 2019 - 2029
  • Figure 6-9: Orthopedic Growth Factor Procedures by Country, Asia-Pacific, 2019 - 2029 (1 of 3)
  • Figure 6-10: Orthopedic Growth Factor Procedures by Country, Asia-Pacific, 2019 - 2029 (2 of 3)
  • Figure 6-11: Orthopedic Growth Factor Procedures by Country, Asia-Pacific, 2019 - 2029 (3 of 3)
  • Figure 6-12: Orthopedic Growth Factor Procedures by Country, Africa, 2019 - 2029
  • Figure 6-13: Orthopedic Growth Factor Market, Global, 2019 - 2029
  • Figure 6-14: Units Sold by Region, Orthopedic Growth Factor Market, Global, 2019 - 2029
  • Figure 6-15: Average Selling Price by Region, Orthopedic Growth Factor Market, Global, 2019 - 2029 (US$)
  • Figure 6-16: Market Value by Region, Orthopedic Growth Factor Market, Global, 2019 - 2029 (US$M)
  • Figure 6-17: Leading Competitors, Orthopedic Growth Factor Market, Global, 2022
目次
Product Code: iDATA_OFG23_MC

In 2022, the global orthopedic growth factor market was valued at $860 million. This is anticipated to increase over the forecast period at a CAGR of 3.5% to reach $1.1 billion.

The orthopedic growth factor market experienced a decline in sales as a result of the Global COVID-19 pandemic. The primary reason for this decrease was the mass cancellation and postponement of scheduled procedures. Although these changes are only temporary, and the market is expected to return to steady growth in the long run, the impact has been significant, and many companies have been forced to accept unprecedented losses in this area for 2020.

DATA TYPES INCLUDED:

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • Sports Medicine Procedure Volumes
  • Market Forecasts Until 2029, and Historical Data to 2022
  • Market Drivers & Limiters for each Sports Medicine market segment
  • Competitive Analysis with Market Shares for Each Segment
  • Recent Mergers & Acquisitions
  • Disease Overviews and Demographic Information
  • Company Profiles, Product Portfolios and SWOT for Top Competitors

PROCEDURE NUMBERS

Aside from the decline and recovery during 2020 and 2022, associated with the delay and cancellation of elective procedures, the total number of orthopedic growth factor procedures is projected to grow at a mid-single-digit rate over the forecast period.

GLOBAL ORTHOPEDIC GROWTH FACTOR MARKET INSIGHTS

The global orthopedic growth factor market has been steadily increasing in value over the past few years. Medtronic has been the main leader in the market with its INFUSE® product. However, Wright Medical has been gaining traction with its AUGMENT® product line, which has seen strong growth since its inception in 2015 and the introduction of AUGMENT® Injectable into the market in 2018.

GLOBAL ORTHOPEDIC GROWTH FACTOR MARKET SHARE INSIGHTS

The global orthopedic growth factor market is lead by three main companies: Medtronic, Stryker, and Cerapedics. In 2022, Medtronic was the leader in the orthopedic growth factor market. Medtronic's INFUSE® product remains the gold standard for spinal fusion therapies.

GLOBAL ORTHOPEDIC GROWTH FACTOR MARKET SEGMENTATION SUMMARY

  • Orthopedic Growth Factor Market

RESEARCH SCOPE SUMMARY

  • Regions: North America (Canada, United States), Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela), Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.), Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine), Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates), Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam), Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)
  • Base Year: 2022
  • Forecast: 2023-2029
  • Historical Data: 2019-2022
  • Quantitative Coverage: Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.
  • Qualitative Coverage: COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.
  • Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.

TABLE OF CONTENT

Orthopedic Growth Factor Market

  • 6.1. Executive Summary
    • 6.1.1. Global Orthopedic Growth Factor Market Overview
    • 6.1.2. Competitive Analysis
    • 6.1.3. Regions Included
  • 6.2. Introduction
  • 6.3. Procedure Numbers
  • 6.4. Market Analysis and Forecast
  • 6.5. Drivers and Limiters
    • 6.5.1. Market Drivers
    • 6.5.2. Market Limiters
  • 6.6. Competitive Market Share Analysis